An AI-powered drug discovery platform that integrates multi-modal biological data and molecular docking simulations to accelerate target identification and predictive efficacy.
An automated multi-cloud (AWS+GCP) pipeline built to accelerate single-cell transcriptomics data processing, genotype imputation, and interactive visualization for brain disorder research
This case study demonstrates how MoSeq and causal AI accurately quantify drug efficacy by mapping behavioral changes directly to specific biological biomarkers.